FDA Grants Priority Review for Arikayce Inhaled Antibiotic for MAC
The FDA accepted Insmed's supplemental new drug application with Priority Review for Arikayce to treat Mycobacterium avium complex (MAC) lung disease.
The FDA accepted Insmed's supplemental new drug application with Priority Review for Arikayce to treat Mycobacterium avium complex (MAC) lung disease.
The American Lung Association initiative seeks to address mistrust, reduce disparities, and expand lung cancer trial participation among underrepresented patient populations.
For patients in the pediatric ICU, pulse oximetry and waveform capnography are valuable tools to monitor the effectiveness of respiratory support and to inform treatment decisions.
Draeger issued a letter to affected customers recommending certain VentStar Resus Neo hoses be removed from where they are used or sold, according to an FDA early alert.
FDA will review Enflonsia's ability to protect high-risk children under 2 years of age during their second RSV season.
A national survey shows that while most laboratories use oscillometry technology, lack of standardized guidelines and high costs limit its growth.
NOxBox reported complaints of oxygen leaks due to failure of the oxygen tubing or tubing connection within the NOxMixer module of the NOxBoxi device, according to the FDA.